Search research articles
Contact Us
Filters
Showing results (71-80 of 118) with videos related to
Page
of 12
Sort By:
Bioorganic & Medicinal Chemistry
|
February 12, 1998
Nitroarylhydroxymethylphosphonic acids as inhibitors of CD45
S A Beers, E A Malloy, W Wu, et al.
Iscience
|
September 13, 2022
Cyclophosphamide depletes tumor infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastoma
Emily R Webb, Julia Moreno-Vincente, Alistair Easton, et al.
Epilepsia
|
March 30, 2021
Localization of interictal discharge origin: A simultaneous intracranial electroencephalographic-functional magnetic resonance imaging study
Negar Tehrani, William Wilson, Daniel J Pittman, et al.
Brain : a Journal of Neurology
|
May 9, 2024
Mapping interictal discharges using intracranial EEG-fMRI to predict postsurgical outcomes
William Wilson, Negar Tehrani, Daniel J Pittman, et al.
Journal of Medicinal Chemistry
|
May 1, 1990
Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II
K H Lee, S A Beers, M Mori, et al.
Carcinogenesis
|
January 23, 2019
Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization
Arindam Banerjee, Charles N Birts, Matthew Darley, et al.
Arthritis and Rheumatism
|
December 1, 2011
Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice
Lindsay M MacLellan, Jennifer Montgomery, Fujimi Sugiyama, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1997
Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation
T Kirchner, D C Argentieri, A G Barbone, et al.
Blood
|
June 28, 2008
Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation
Stephen A Beers, Claude H T Chan, Sonya James, et al.
Communications Biology
|
September 3, 2021
On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation
Joshua M Sopp, Shirley J Peters, Tania F Rowley, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 118) with videos related to
Sort By:
Page
of 12
Bioorganic & Medicinal Chemistry
|
February 12, 1998
Nitroarylhydroxymethylphosphonic acids as inhibitors of CD45
S A Beers, E A Malloy, W Wu, et al.
Iscience
|
September 13, 2022
Cyclophosphamide depletes tumor infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastoma
Emily R Webb, Julia Moreno-Vincente, Alistair Easton, et al.
Epilepsia
|
March 30, 2021
Localization of interictal discharge origin: A simultaneous intracranial electroencephalographic-functional magnetic resonance imaging study
Negar Tehrani, William Wilson, Daniel J Pittman, et al.
Brain : a Journal of Neurology
|
May 9, 2024
Mapping interictal discharges using intracranial EEG-fMRI to predict postsurgical outcomes
William Wilson, Negar Tehrani, Daniel J Pittman, et al.
Journal of Medicinal Chemistry
|
May 1, 1990
Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II
K H Lee, S A Beers, M Mori, et al.
Carcinogenesis
|
January 23, 2019
Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization
Arindam Banerjee, Charles N Birts, Matthew Darley, et al.
Arthritis and Rheumatism
|
December 1, 2011
Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice
Lindsay M MacLellan, Jennifer Montgomery, Fujimi Sugiyama, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1997
Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation
T Kirchner, D C Argentieri, A G Barbone, et al.
Blood
|
June 28, 2008
Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation
Stephen A Beers, Claude H T Chan, Sonya James, et al.
Communications Biology
|
September 3, 2021
On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation
Joshua M Sopp, Shirley J Peters, Tania F Rowley, et al.
Page
of 12